U.S. Banks Stock News

If you are wondering whether Cabot's current share price reflects its true worth, this article breaks down the key valuation clues you can use to judge it for yourself. Cabot recently closed at US$74.11, with returns of 9.3% over the past week, a 2.3% decline over the past month, 10.5% year to date and a 7.7% decline over the past year. Taken together, these figures give mixed signals about how the market is currently pricing the stock. Recent coverage around Cabot has focused on its...

Wondering if PTC Therapeutics at around US$66.13 is giving you a fair deal or asking too much for its future potential? This article breaks down what the current price might be implying. The stock has seen a mixed run recently, with a 1.3% gain over the last 7 days, a 2.4% decline over 30 days, a 13.8% decline year to date, a 21.9% return over 1 year, and 36.5% and 34.4% over 3 and 5 years respectively. Recent attention on PTC Therapeutics has centered on how investors are reassessing the...

Wondering if Generac Holdings at around US$194 per share still offers value, or if the easy gains are already behind it? This article focuses squarely on what the current price implies. The stock has had a mixed run, with a 2.5% decline over the last week and a 17.8% decline over the last month, while still sitting on returns of 37.8% year to date and 53.0% over the past year. Recent coverage of Generac has highlighted renewed interest in companies linked to backup power and grid resilience...

For readers wondering whether Brunswick's share price still offers value after a strong run, or if most of the potential upside is already reflected, this article focuses on what the numbers indicate about its valuation. Brunswick closed at US$70.95, with a 0.7% return over the last 7 days, a 12.4% decline over 30 days, a 6.5% decline year to date, and a 36.2% gain over 1 year. Over 3 years and 5 years the returns were declines of 7.3% and 19.0% respectively. Recent price moves are set...

On March 13, 2026, Liquidia’s Chief Medical Officer Rajeev Saggar sold 35,365 shares of common stock for about US$1.28 million, trimming roughly one sixth of his direct holdings. This sizeable insider sale comes while Liquidia’s core business appears to be progressing, highlighted by YUTREPIA’s reach to more than 2,900 patients and two straight profitable quarters. We’ll now examine how this sizeable insider sale amid ongoing YUTREPIA momentum may influence Liquidia’s broader investment...

What recent price moves suggest about Sify Technologies (SIFY) Sify Technologies (SIFY) has seen sharp swings recently, with a 3.1% decline over the past day, a 7.1% drop across the past week, and a 20.4% slide over the past month. See our latest analysis for Sify Technologies. The recent slide in Sify Technologies' share price contrasts with its very large 1 year total shareholder return of 193.85%. At the same time, the 5 year total shareholder return of a 40.28% loss underlines how quickly...

Stryker (SYK) is back in focus after a cyberattack disrupted its manufacturing and electronic ordering systems, with the company now reporting restored access across most sites and renewed progress on production and fulfillment. See our latest analysis for Stryker. The recent cyberattack headlines come after a weaker patch for the stock, with a 30 day share price return of a 14.7% decline and a 1 year total shareholder return of a 9.3% loss, pointing to fading momentum despite positive multi...

Earlier this week, Progress Software announced that its ShareFile document collaboration platform now supports eIDAS-compliant Advanced and Qualified Electronic Signatures for UK and EU customers, integrating identity verification via Qualified Trust Service Providers into a single, auditable workflow. This move positions ShareFile as an all-in-one workspace for regulated industries, consolidating collaboration, high-assurance signing, and secure storage without relying on separate...

Earlier this week, Gates Industrial Corporation, a manufacturer of engineered power transmission and fluid power solutions, was lifted by easing geopolitical tensions as postponed military action against Iran reduced perceived risk for globally exposed industrial companies. This shift in geopolitical risk sentiment matters for Gates because its end markets, including construction equipment and manufacturing, are closely tied to global economic stability and confidence in longer-term capital...

If you are wondering whether Ligand Pharmaceuticals at around US$195 a share still offers value, the next sections will walk through what the current price might be implying about the business. The stock has delivered an 81.6% return over 1 year and 165.7% over 3 years, while the shorter term picture shows a 4.6% decline over 7 days alongside modest gains of 2.1% over 30 days and 2.8% year to date. Recent coverage of Ligand Pharmaceuticals has focused on its role in the wider pharmaceuticals...

Sportradar Group (NasdaqGS:SRAD) has introduced Playradar, a new iGaming brand that combines live sports streaming with casino style gaming experiences. The company has also expanded its relationship with Hard Rock Bet to include official PGA TOUR and UFC data plus more advanced in play betting features. These updates extend Sportradar's role beyond core sports data into hybrid gaming products while deepening ties with a major US betting operator. Sportradar Group, trading at $17.15, is...

On March 16, 2026, at its Global Conference, XP Inc. drew attention as analysts highlighted a stronger-than-expected start to the year driven by heavier retail equity trading and anticipated client reimbursements from Brazil’s deposit insurance fund (FGC) flowing back into XP’s platform. The interesting angle for investors is how these FGC-related inflows, if reinvested into fixed-income products, could generate upfront commissions that temporarily enhance XP’s revenue mix and fee...

In recent commentary on Cullen/Frost Bankers, analysts highlighted that while Frost Bank’s prior quarterly results were solid, its revenue growth over the past two years has slowed relative to peers and its own five-year trend. An interesting takeaway is that consensus now points to a projected decline in tangible book value per share over the next 12 months, raising fresh questions about the bank’s capital generation and profitability outlook. Next, we’ll examine how slowing revenue growth...

If you are wondering whether Boyd Gaming is priced fairly or if the market is missing something, this breakdown will help you assess what you are really paying for at the current share price. The stock last closed at US$80.16, with a 1.1% decline over the past week and a 5.6% decline over the past month. Over longer periods, the 1 year return is 22.1%, and the 3 year and 5 year returns are 28.8% and 36.1% respectively. Recent attention on Boyd Gaming has focused on its share price...

Aptiv (NYSE:APTV) announced that Javed Khan, Executive Vice President and President of Intelligent Systems, is resigning to become CEO of a software and AI company. CEO Kevin Clark will take on Khan's responsibilities on an interim basis while Aptiv searches for a successor. Aptiv shares recently closed at $67.04, with the stock showing a 10.6% gain over the past year, a 14.5% decline year to date, and a 40.2% decline over three years. The Intelligent Systems segment is an important area...

If you are wondering whether Corpay's current share price reflects its underlying worth, you are not alone. This article focuses squarely on what you might be paying for each dollar of quality in the business. Corpay recently closed at US$284.93, with returns of a 0.9% decline over 7 days, a 13.7% decline over 30 days, a 5.2% decline year to date, a 17.8% decline over 1 year, alongside longer term returns of 35.1% over 3 years and 1.9% over 5 years. Recent coverage has highlighted Corpay in...

Wondering if Portland General Electric at around US$51.71 is offering fair value right now, or if the recent share price leaves something on the table for you? The stock is up 1.5% over the past week and 6.7% year to date, while the last 12 months show a 22.0% return despite a 3.3% pullback over the past month. Recent attention on regulated utilities and the broader power grid story has kept Portland General Electric in focus, as investors weigh the role of electricity providers in long term...

If you are wondering whether Lazard at around US$39.11 is a bargain or a value trap, you are not alone. That question is exactly what this article aims to unpack. The stock has been under pressure recently, with a 0.4% decline over the last 7 days, a 24.3% decline over 30 days, and a 21.4% decline year to date. The 1 year return sits at a 5.6% decline, and the 3 year and 5 year returns are 36.7% and 11.2% respectively. Recent attention on Lazard has been driven by broader market...

Restaurant Brands International (NYSE:QSR) has appointed Chris Padoan as Chief Operating Officer for Popeyes U.S. and Canada. The company is expanding its Popeyes field operations team by 75% to support underperforming restaurants. These moves follow nearly 3% same store sales declines and weaker franchisee profitability at Popeyes. For investors tracking Restaurant Brands International at a share price of $71.42, this reset at Popeyes comes on top of a mixed recent return profile. The...

If you are wondering whether Western Union's share price reflects its true worth, it helps to step back and look at how the current market price lines up with the business fundamentals. The stock last closed at US$8.73, with returns of 3.2% decline over 7 days, 10.0% decline over 30 days, 5.4% decline year to date, 7.4% decline over 1 year, a 2.1% gain over 3 years, and a 49.1% decline over 5 years, which may suggest shifting views on its risk and reward profile. Recent coverage has focused...

Monte Rosa Therapeutics (GLUE) has moved into focus after signing a supply agreement with Johnson & Johnson to evaluate MRT-2359 plus ERLEADA in a planned Phase 2 trial for metastatic castration-resistant prostate cancer. See our latest analysis for Monte Rosa Therapeutics. Alongside the Johnson & Johnson supply agreement and fresh MRT-2359 data, Monte Rosa’s share price has eased recently. The stock has a 30 day share price return of 15% and a 90 day share price return decline of 11%. At the...

Brookdale Senior Living (NYSE:BKD) has been recognized as a "Best Pet Workplace" by WUF World. The company is the first senior living provider to receive this designation. The award highlights Brookdale's focus on pet friendly policies for residents and associates. Brookdale Senior Living, trading at $13.82, now carries a "Best Pet Workplace" label that sets it apart within the senior living space. Over the past year, the stock has returned 124.7%, and it is up 27.5% year to date. This may...

Earlier in March, Campbell's reported fiscal Q2 2026 results showing lower net sales and EBIT, as storms in January disrupted shipments and lifted supply chain costs. These results come amid two years of falling unit sales and a projected 2.6% sales decline over the next 12 months, underscoring demand pressure in Campbell's core categories. Next, we’ll examine how weaker demand and weather-related supply chain disruptions might reshape Campbell's previously outlined investment...

Wondering whether WD-40 at around US$201 a share looks expensive, cheap, or somewhere in between? This article breaks down what the current price really represents. The stock is up 2.3% year to date, but that sits alongside a 5.9% decline over the last week, an 18.1% decline over the last month, and a 15.3% decline over the last year, which can change how investors think about both opportunity and risk. Recent coverage has focused on WD-40 as a long established brand in household products,...